Molecular Panorama of Therapy Resistance in Prostate Cancer: A Pre-Clinical and Bioinformatics Analysis for Clinical Translation

The dysregulation in molecular profile of prostate cancer including upregulation of STAT3 and PI3K/Akt, downregulation of STAT3, and aberrant expression of non-coding RNAs are determining factor for response of cancer cells to chemotherapy.